Name: UMIN ID:
Unique ID issued by UMIN | UMIN000014197 |
---|---|
Receipt number | R000015992 |
Scientific Title | Evaluation of minimal residual disease,immune cells dynamics and quality of life in bortezomib based induction therapy followed by lenalidomide maintenance for newly diagnosed patients with multiple myeloma ineligible for stem cell transplantation. |
Date of disclosure of the study information | 2014/07/01 |
Last modified on | 2018/04/28 12:18:44 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/06/06 20:23:56 | ||
2 | Update | 2018/04/28 12:18:44 | UMIN ID1 |